Exact Mass: 318.065882
Exact Mass Matches: 318.065882
Found 295 metabolites which its exact mass value is equals to given mass value 318.065882,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Brompheniramine
Brompheniramine (also known as Bromfed, Bromfenex, and Dimetane) is an antihistamine drug of the propylamine class. It is commonly available over the counter and is indicated for the treatment of the symptoms of the common cold and allergic rhinitis, such as runny nose, itchy eyes, watery eyes, and sneezing. It is a first-generation antihistamine; Brompheniramine (also known as Bromfed, Bromfenex, and Dimetane) is an antihistamine drug of the propylamine class. It is commonly available over the counter and is indicated for the treatment of the symptoms of the common cold and allergic rhinitis, such as runny nose, itchy eyes, watery eyes, and sneezing. It is a first-generation antihistamine. -- Wikipedia; Histamine H1 antagonist used in treatment of allergies, rhinitis, and urticaria. [HMDB] Brompheniramine (also known as Bromfed, Bromfenex, and Dimetane) is an antihistamine drug of the propylamine class. It is commonly available over the counter and is indicated for the treatment of the symptoms of the common cold and allergic rhinitis, such as runny nose, itchy eyes, watery eyes, and sneezing. It is a first-generation antihistamine; Brompheniramine (also known as Bromfed, Bromfenex, and Dimetane) is an antihistamine drug of the propylamine class. It is commonly available over the counter and is indicated for the treatment of the symptoms of the common cold and allergic rhinitis, such as runny nose, itchy eyes, watery eyes, and sneezing. It is a first-generation antihistamine. -- Wikipedia; Histamine H1 antagonist used in treatment of allergies, rhinitis, and urticaria. R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AB - Substituted alkylamines D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents
Lecanoricacid
D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates Lecanoric acid is a histidine-decarboxylase inhibitor isolated from fungus. The inhibition by lecanoric acid is competitive with histidineand noncompetitive with pyridoxal phosphate. Lecanoric acid did not inhibit aromatic amino acid decarboxylase[1].
Melanin
Dermal melanin is produced by melanocytes, which are found in the stratum basale of the epidermis. Although human beings generally possess a similar concentration of melanocytes in their skin, the melanocytes in some individuals and races more frequently or less frequently express the melanin-producing genes, thereby conferring a greater or lesser concentration of skin melanin. Some individual animals and humans have no or very little melanin in their bodies, which is a condition known as albinism. Higher eumelanin levels also can be a disadvantage, however, beyond a higher disposition toward vitamin D deficiency. Dark skin is a complicating factor in the laser removal of port-wine stains. Effective in treating fair skin, lasers generally are less successful in removing port-wine stains in Asians and people of African descent. Higher concentrations of melanin in darker-skinned individuals simply diffuse and absorb the laser radiation, inhibiting light absorption by the targeted tissue. Melanin similarly can complicate laser treatment of other dermatological conditions in people with darker skin. Under the microscope melanin is brown, non-refractile and finely granular with individual granules having a diameter of less than 800 nanometers. This differentiates melanin from common blood breakdown pigments which are larger, chunky and refractile and range in color from green to yellow or red-brown. In heavily pigmented lesions, dense aggregates of melanin can obscure histologic detail. A dilute solution of potassium permanganate is an effective melanin bleach. Pigments causing darkness in skin, hair, feathers, etc. They are irregular polymeric structures and are divided into three groups: allomelanins in the plant kingdom and eumelanins and phaeomelanins in the animal kingdom. Because melanin is an aggregate of smaller component molecules, there are a number of different types of melanin with differing proportions and bonding patterns of these component molecules. Both pheomelanin and eumelanin are found in human skin and hair, but eumelanin is the most abundant melanin in humans, as well as the form most likely to be deficient in albinism. Freckles and moles are formed where there is a localized concentration of melanin in the skin. They are highly associated with pale skin. Melanin is a biopolymer and a neuropeptide. In the early 1970s, John McGinness, Peter Corry, and Peter Proctor reported that melanin is a high-conductivity organic semiconductor (Science, vol 183, 853-855 (1974)). Studies revealed that melanin acted as a voltage-controlled solid-state threshold switch. Further, it emitting a flash of light electroluminescence when it switched. Dermal melanin is produced by melanocytes, which are found in the stratum basale of the epidermis. Although human beings generally possess a similar concentration of melanocytes in their skin, the melanocytes in some individuals and races more frequently or less frequently express the melanin-producing genes, thereby conferring a greater or lesser concentration of skin melanin. Some individual animals and humans have no or very little melanin in their bodies, which is a condition known as albinism.
Clotiazepam
Clotiazepam is only found in individuals that have used or taken this drug. It is a benzodiazepine derivative, not approved for sale in the U.S. or Canada, but has been approved in the U.K. It is a schedule IV drug in Canada.Clotiazepam acts at the benzodiazepine receptors (BZD). This agonizes the action of GABA, increasing the frequency of opening of the channel chlorinates and penetration of the ions chlorinates through the ionophore. Increase in membrane polarization decreases the probability of discharge of neurons. N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
2-(3,4-dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-4-one
Dihydroisorhamnetin
Dihydroisorhamnetin is found in beverages. Dihydroisorhamnetin is isolated from Dillenia indica (elephant apple). Isolated from Dillenia indica (elephant apple). Dihydroisorhamnetin is found in beverages and fruits.
Mycochromone
Mycochromone is produced by Mycosphaerella rosigena. Mycotoxin. Production by Mycosphaerella rosigena. Mycotoxin.
Tamarixetin
Isolated from Blumea balsamifera (sambong). 3,3,5,7-Tetrahydroxy-4-methoxyflavanone is found in tea. Tamarixetin is a flavanoid component of the Ginko Biloba extract. Exhibits antioxidant properties.
Dexbrompheniramine
Dexbrompheniramine is only found in individuals that have used or taken this drug. It is an antihistamine used to treat allergic conditions such as hay fever or urticaria. Dexbrompheniramine competitively binds to the histamine H1-receptor. It competes with histamine for the normal H1-receptor sites on effector cells of the gastrointestinal tract, blood vessels and respiratory tract. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine. R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AB - Substituted alkylamines D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
Fenofibric acid
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent Fenofibric acid, an active metabolite of fenofibrate, is a PPAR activitor, with EC50s of 22.4 μM, 1.47 μM, and 1.06 μM for PPARα, PPARγ and PPARδ, respectively; Fenofibric acid also inhibits COX-2 enzyme activity, with an IC50 of 48 nM.
1-Methyl-3a-(1,1-dimethyl-2-propenyl)-6-bromo-1,2,3,3a-tetrahydropyrrolo[2,3-b]indole
1,6-Dihydroxy-3,5,7-trimethoxyxanthone
1,6-Dihydroxy-3,5,7-trimethoxyxanthen-9-one is a natural product found in Cystopteris fragilis and Polygala tenuifolia with data available.
(+)-Dihydroisorhamnetin
A tetrahydroxyflavanone that is taxifolin in which the hydroxy group at position 3 is substituted by a methoxy group. It is a metabolite of taxifolin.
Fenofibric acid
A monocarboxylic acid that is 2-methylpropanoic acid substituted by a 4-(4-chlorobenzoyl)phenoxy group at position 2. It is a metabolite of the drug fenofibrate. C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent CONFIDENCE standard compound; EAWAG_UCHEM_ID 337 CONFIDENCE standard compound; INTERNAL_ID 2056 Fenofibric acid, an active metabolite of fenofibrate, is a PPAR activitor, with EC50s of 22.4 μM, 1.47 μM, and 1.06 μM for PPARα, PPARγ and PPARδ, respectively; Fenofibric acid also inhibits COX-2 enzyme activity, with an IC50 of 48 nM.
Antibiotic AGI-B4
(3R)-4-methoxy-3,7,2,3-tetrahydroxyisoflavanonol|(3S)-4-methoxy-3,7,2,3-tetrahydroxyisoflavanonol|isodalparvinol B|isodarparvinol B
F390C
A member of the class xanthones which consists of a dihydroxanthone skeleton substituted by hydroxy groups at positions 4 and 8, a hydroxymethyl group at position 6 and a methoxycarbonyl group at position 4a (the 4R,4aS stereoisomer). It is isolated from Penicillium and exhibits potent antitumour activity against both human and murine tumour cell lines.
Botrallin
An organic heterotricyclic compound that is 2,4a-dihydro-6H-benzo[c]chromen-6-one substituted by hydroxy groups at positions 1 and 7, an oxo group at position 2, methoxy groups at positions 3 and 9, and a methyl group at position 4a. It is isolated from Hyalodendriella species.
(1R,3S)-6,9-dihydroxy-1-methyl-5,10-dioxo-3,4,5,10-tetrahydro-1H-naphtho[2,3-c]pyran-3-yl acetic acid|8-hydroxydihydrokalafungin|Actinorhodine
6-Sulfo-chinovose-glycerin|6-Sulfo-chinovose-glycerol|6-Sulfo-O-alpha-D-chinopyranosyl-(1->1)-glycerin|6-Sulfo-O-alpha-quino-pyranosyl-(1->1)-glycerin
1-Me ether-Anhydrofusarubinlactol|5,10-dihydroxy-1,7-dimethoxy-3-methyl-1H-naphtho-<2,3-c>-pyran-6,9-dione
Chaetocyclinone B
An organic heterotricyclic compound that is 1H,10H-pyrano[4,3-b]chromene substituted by methyl, hydroxy, methoxy, methoxycarbonyl, and oxo groups at positions 3, 6, 7, 9 and 10, respectively. It is produced by cultures of Chaetomium sp. Goe 100/2, which was isolated from marine algae.
2,6-dihydroxy-4-methoxy-2-[(2,4-dihydroxyphenyl)methyl]-3(2H)-benzofuranone|cudrauronol
2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-8-methylchroman-4-one
4-(2,2-bithiophen-5-yl)but-3-ynyl 3-methylbutanoate|5-(4-isovaleroyloxybut-1-ynyl)-2,2-bithiophene|5-(4-isovaleryloxy-1-butynyl)-2,2-bithiophene
1,8-dihydroxy-2,3,7-trimethoxy-xanthen-9-one|1,8-Dihydroxy-2,3,7-trimethoxyxanthon|2,3,7-Tri-Me ether-1,2,3,7,8-Pentahydroxyxanthone
3-(2,3,4-Trihydroxyphenyl)-3,4-dihydro-6,7-(methylenebisoxy)-2H-1-benzopyran-4-ol
(3R*)-3-(3,4-dihydroxybenzyl)-3,7,8-trihydroxychroman-4-one|haematoxylone
1,8-dihydroxy-3,4,5-trimethoxyxanthone|3-methyl corymbiferin
2-O-(3,4-Dihydroxybenzoyl)-2,4,6-trihydroxyphenylacetic acid
(3R,4R)-7,2,4,2-tetrahydroxy-4,5-methylenedioxyisoflav-3-ene
3-epi-Padmatin
(2R)-2,3-Dihydro-2alpha-(3,4-dihydroxyphenyl)-3alpha,5-dihydroxy-7-methoxy-4H-1-benzopyran-4-one is a natural product found in Dittrichia graveolens with data available.
MEGxp0_001397
(2R,3R)-3,3,5,7-Tetrahydroxy-4-methoxyflavanone is a natural product found in Chromolaena odorata, Canarium album, and other organisms with data available.
Drimiopsin D
methyl 2-(2,6-dihydroxy-4-methylbenzoyl)-3,5-dihydroxybenzoate
(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxy-2,3-dihydrochromen-4-one
methyl 2,8-dihydroxy-6-(hydroxymethyl)-9-oxo-1,2-dihydroxanthene-1-carboxylate
methyl 4,8-dihydroxy-6-(hydroxymethyl)-9-oxo-4,4a-dihydroxanthene-1-carboxylate
(2S,3S)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-6-methyl-2,3-dihydrochromen-4-one
BROMPHENIRAMINE
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AB - Substituted alkylamines D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents
dexbrompheniramine
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AB - Substituted alkylamines D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
methyl 2-(2,6-dihydroxy-4-methylbenzoyl)-3,5-dihydroxybenzoate
(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxy-2,3-dihydrochromen-4-one
(2S,3S)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-6-methyl-2,3-dihydrochromen-4-one
methyl 2,8-dihydroxy-6-(hydroxymethyl)-9-oxo-1,2-dihydroxanthene-1-carboxylate
2-{7-hydroxy-11-methyl-2,9-dioxo-12,15-dioxatetracyclo[8.4.1.0¹,¹⁰.0³,⁸]pentadeca-3,5,7-trien-13-yl}acetic acid
2-{7-hydroxy-11-methyl-2,9-dioxo-12,15-dioxatetracyclo[8.4.1.0¹,¹⁰.0³,⁸]pentadeca-3,5,7-trien-13-yl}acetic acid_major
2-{7-hydroxy-11-methyl-2,9-dioxo-12,15-dioxatetracyclo[8.4.1.0¹,¹⁰.0³,⁸]pentadeca-3,5,7-trien-13-yl}acetic acid_53.1\\%
2-{7-hydroxy-11-methyl-2,9-dioxo-12,15-dioxatetracyclo[8.4.1.0¹,¹⁰.0³,⁸]pentadeca-3,5,7-trien-13-yl}acetic acid_minor
methyl 2-(2,6-dihydroxy-4-methylbenzoyl)-3,5-dihydroxybenzoate_minor
methyl 2-(2,6-dihydroxy-4-methylbenzoyl)-3,5-dihydroxybenzoate_major
2-{7-hydroxy-11-methyl-2,9-dioxo-12,15-dioxatetracyclo[8.4.1.0¹,¹?.0³,?]pentadeca-3,5,7-trien-13-yl}acetic acid
clotiazepam
N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
4-(5-CHLORO-2-METHOXYBENZOYL)BENZOIC ACID ETHYL ESTER
(S)-7-PHENYL-2-(PYRROLIDIN-2-YL)THIAZOLO[5,4-D]PYRIMIDINE HYDROCHLORIDE
(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)methyl4-methylbenzene sulfonate
1-(4-chlorophenyl)-2,3,4,9-tetrahydro-1H-beta-carboline hydrochloride
tert-butyl 2-(4-chlorophenyl)sulfonyl-2-methylpropanoate
Belinostat
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XH - Histone deacetylase (hdac) inhibitors D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents
2-Methyl-2-propanyl 3-bromo-1-oxa-2,8-diazaspiro[4.5]dec-2-ene-8- carboxylate
Dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate
5-(4-Methoxybiphenyl-3-YL)-1,2,5-thiadiazolidin-3-one 1,1-dioxide
(7R,8R)-Agi-B4
A member of the class of xanthones that is methyl (1S)-2,9-dihydro-1H-xanthene-1-carboxylate substituted by hydroxy groups at positions 2 and 8, a hydroxymethyl group at position 6 and an oxo group at position 9. It has been isolated from the sea fan derived fungus Aspergillus sydowii.
Flutemazepam
C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
2-Hydroxy-6-[2-(3,4-dihydroxyphenyl-5-methoxy)-2-oxoethyl]benzoic acid
A monohydroxybenzoic acid that is benzoic acid substituted by a hydroxy group at position 2 and a 2-(3,4-dihydroxy-5-methoxyphenyl)-2-oxoethyl group at position 6. It has been isolated from the roots of Scorzonera judaica.
2-Chloro-1-[3-(4-methylphenyl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]ethanone
N-{1-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-1H-1,2,4-triazol-3-yl}-N,N-dimethyliminoformamide
2-(7-Hydroxy-11-methyl-2,9-dioxo-12,15-dioxatetracyclo[8.4.1.01,10.03,8]pentadeca-3(8),4,6-trien-13-yl)acetic acid
2,7-dihydroxy-5-[(4-hydroxy-6-oxopyran-2-yl)methyl]-2-methyl-3H-chromen-4-one
8-Hydroxy-1-(1-hydroxyethyl)-5,7-dimethoxynaphtho[2,3-c]furan-4,9-dione
2,7-dihydroxy-2-[(4-hydroxy-6-oxopyran-2-yl)methyl]-5-methyl-3H-chromen-4-one
1,6-Dihydroxy-3-methyl-7,9-dimethoxy-1H-naphtho[2,3-c]pyran-5,10-dione
3,6,8,9-Tetrahydroxy-3-methyl-1-oxo-2,4-dihydroanthracene-2-carboxylic acid
[(2S,3S,4S,5R,6S)-6-[(2S)-2,3-dihydroxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid
cylindol A
A benzoate ester that is methyl 4-hydroxybenzoate bearing a 2-hydroxy-5-(methoxycarbonyl)phenoxy group at position 3. It is isolated from the rhizomes of Imperata cylindrica and has been found to exhibit inhibitory activity against 5-lipoxygenase.
3-[[(3-Acetylanilino)-oxomethyl]amino]-2-thiophenecarboxylic acid methyl ester
2-[[2-[(E)-1-thiophen-2-ylethylideneamino]oxyacetyl]amino]benzoic acid
methyl (4R,4aS)-4,8-dihydroxy-6-(hydroxymethyl)-9-oxo-4,9-dihydro-4aH-xanthene-4a-carboxylate
(11E)-11-diazo-4,9-dihydroxy-2-methylbenzo[b]fluorene-5,10-dione
[(2S,3S,4S,5R,6S)-6-[(2R)-2,3-bis(oxidanyl)propoxy]-3,4,5-tris(oxidanyl)oxan-2-yl]methanesulfonic acid
5,6,7-Trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-2,3-dihydrochromen-4-one
5,6,7-Trihydroxy-2-(3-hydroxy-5-methoxyphenyl)-2,3-dihydrochromen-4-one
1,1-Dimethyl-4-phenylpiperazinium iodide
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D005731 - Ganglionic Stimulants D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018679 - Cholinergic Agonists
N-(5-phosphonatopyridoxyl)-D-alaninate(2-)
Dianion of N-(5-phosphopyridoxyl)-D-alanine having anionic carboxy, hydroxy and phosphate groups and the secondary amino group and pyridine nitrogen protonated.
N-(5-phosphonatopyridoxyl)-L-alaninate(2-)
An organophosphate oxoanion that is the dianion of N-(5-phosphopyridoxyl)-L-alanine having anionic carboxy, hydroxy and phosphate groups with the secondary amino group and pyridine nitrogen protonated.
(2r,3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-3,7-dihydroxy-2,3-dihydro-1-benzopyran-4-one
(2r,3r)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-5-methoxy-2,3-dihydro-1-benzopyran-4-one
methyl 6-hydroxy-7-methoxy-3-methyl-10-oxo-1h-pyrano[4,3-b]chromene-9-carboxylate
8-hydroxy-1-[(1r)-1-hydroxyethyl]-5,7-dimethoxynaphtho[2,3-c]furan-4,9-dione
(3s)-3,5,7-trihydroxy-3-(3-hydroxy-4-methoxyphenyl)-2h-1-benzopyran-4-one
[(1r,10s,11s,13r)-7-hydroxy-11-methyl-2,9-dioxo-12,15-dioxatetracyclo[8.4.1.0¹,¹⁰.0³,⁸]pentadeca-3,5,7-trien-13-yl]acetic acid
2-(2,4-dihydroxy-6-methylbenzoyloxy)-4-hydroxy-6-methylbenzoic acid
2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-8-methoxy-2,3-dihydro-1-benzopyran-4-one
methyl (4s,5r)-4,7-dihydroxy-9-methyl-6-oxo-4h,5h-oxepino[2,3-b]chromene-5-carboxylate
(2s,7'r)-5-hydroxy-3-oxospiro[1-benzofuran-2,1'-cycloheptan]-3'-ene-3',7'-dicarboxylic acid
2-hydroxy-4-methoxy-6-(4-methoxy-2-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)benzoic acid
methyl 2-(2,6-dihydroxy-4-methylbenzoyl)-3,6-dihydroxybenzoate
(2s)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-methoxy-2,3-dihydro-1-benzopyran-4-one
(1r)-5,10-dihydroxy-1,7-dimethoxy-3-methyl-1h-cyclohexa[g]isochromene-6,9-dione
1,2,4,6,8-pentahydroxyxanthone
{"Ingredient_id": "HBIN000633","Ingredient_name": "1,2,4,6,8-pentahydroxyxanthone","Alias": "NA","Ingredient_formula": "C16H14O7","Ingredient_Smile": "NA","Ingredient_weight": "318.282","OB_score": "NA","CAS_id": "145523-72-4","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9607","PubChem_id": "NA","DrugBank_id": "NA"}
1,3-dihydroxy-2,4,7-trimethoxyxanthone
{"Ingredient_id": "HBIN001177","Ingredient_name": "1,3-dihydroxy-2,4,7-trimethoxyxanthone","Alias": "NA","Ingredient_formula": "C16H14O7","Ingredient_Smile": "COC1=CC2=C(C=C1)OC3=C(C2=O)C(=C(C(=C3OC)O)OC)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6163","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1,7-dihydroxy-3,4,8- trimethoxy xanthones
{"Ingredient_id": "HBIN002013","Ingredient_name": "1,7-dihydroxy-3,4,8- trimethoxy xanthones","Alias": "NA","Ingredient_formula": "C16H14O7","Ingredient_Smile": "COC1=C(C2=C(C(=C1)O)C(=O)C3=C(O2)C=CC(=C3OC)O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "43027","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2',3,5,5',7-pentahydroxyflavanone; (2r,3r)-form,5'-me ether
{"Ingredient_id": "HBIN003910","Ingredient_name": "2',3,5,5',7-pentahydroxyflavanone; (2r,3r)-form,5'-me ether","Alias": "NA","Ingredient_formula": "C16H14O7","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8976","PubChem_id": "NA","DrugBank_id": "NA"}
